Approval · Notice of Compliance 28232 · 2022
DUODOPA: Notice of Compliance 28232
Issued May 19, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28232
- Date
- May 19, 2022
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate drug product manufacturing site, Addition of micronization site for the drug product, Change to the drug product manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DUODOPA | Not yet assigned | — |